Historical record - last NADAC effective date: 11/19/2014

Product Information

AMLODIPINE-ATORVAST 2.5-10 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $3.6960 per EA under NDC 43598032330. Its NADAC has been published 84 times since May 14, 2014.

FDA first approved this application on Mar 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 2.5-10 MG

Amlodipine besylate and Atorvastatin calcium
$3.6960per EA

Strength

2.5; 10 mg/1; mg/1

NDC

43598032330

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/19/2014

Approval Type

Generic (ANDA)

FDA Application

ANDA203874

FDA Approved

3/7/2014

TE Code

AB

On Market Since

3/17/2014

Pharmacological Classes

Calcium Channel Antagonists
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 2.5-10 MG has been published 84 times since May 14, 2014, and over the history we have for it it has declined 8.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.6960 per EA
All-time high$4.0409 (Nov 12, 2014)
All-time low$3.6960 (Nov 19, 2014)
Median price$3.6960
Average price$3.8069
Largest weekly change-8.5% (Nov 19, 2014)
Weeks tracked84
Tracking sinceMay 14, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-8.5%

Last surveyed Dec 16, 2015 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine besylate and Atorvastatin calcium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 2.5-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 2.5-10 MG, manufactured by Dr. Reddy's Laboratories Inc., is $3.6960 per EA (NDC 43598032330), effective Dec 16, 2015.

How has the price of AMLODIPINE-ATORVAST 2.5-10 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 2.5-10 MG has declined 8.5%. It has been tracked across 84 weekly CMS publications since May 14, 2014.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 2.5-10 MG?

Since May 14, 2014, the NADAC for AMLODIPINE-ATORVAST 2.5-10 MG has ranged from a low of $3.6960 (Nov 19, 2014) to a high of $4.0409 (Nov 12, 2014), with a median of $3.6960 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 2.5-10 MG?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-ATORVAST 2.5-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-ATORVAST 2.5-10 MG?

AMLODIPINE-ATORVAST 2.5-10 MG (NDC 43598032330) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.